|
Market Cap (5-Jun) $102,067,456 (1,050th) |
Close (30-Jun) $0.062 |
Volume (30-Jun) 526,676 |
Shortsold (26-May) 683,172 (0.11%) (444th) |
|
52w High $0.67 |
52w Low $0.165 |
P/E 10.78 |
EPS -0.03 |
DXB released this announcement to the ASX on 17 February 2023, 8:32. The announcement is marked as price sensitive, and is 3 page(s) in length and 349.24kb in size.
You can view all announcements from DXB and see how they appear on a price chart on the announcements page.
At the date of this announcement, DXB was 0.058% short sold according to ASIC data. It was ranked the 509th most shorted stock on the ASX. It is now ranked as the 444th most shorted stock on the ASX with 0.114% of total shares short sold as of the latest reported data (26 May 2026).
| Other Recent Announcements from DXB | |
|---|---|
| Application for quotation of securities - DXB | 29 June 2023, 9:01 |
| Application for quotation of securities - DXB | 29 June 2023, 9:00 |
| Application for quotation of securities - DXB | 29 June 2023, 8:59 |
| DXB to Receive $2.8m in Prepayment of R&D Tax Incentive | 17 February 2023, 8:32 |
| Successful Completion of DSMB Review of Phase 3 FSGS Trial | 9 February 2023, 9:04 |
| Quarterly Appendix 4C and Activities Report | 31 January 2023, 8:45 |
| FDA Confirms Inclusion of Paediatrics in ACTION3 Study | 12 January 2023, 9:16 |
You must be logged in to post a reply.
Dimerix 